top of page
WHH Mentorship Council
TAxolcur llc
Founded in
2021
Market type
B2C
Fund to raise
1 - 5 Million USD
Funding stage
Series A
Website/App
Operation geo
West Berlin
Target gro roadmap
Founders
Paul H. Schwartz
CEO
Mewa Singh-Sandhu
COO
Michael R. Briggs
CSO
Problem addressing
NACO supported blood banks -- Indian Red cross (multiple locations), Lions, NTR Trust, Lifeline, Arpan etc.,
Company overview
It is proven that paclitaxel, the active medicine in TaxolCurTM, is an effective cancer therapy. It is an FDA approved therapeutic.
Until now, it has not been used in dogs because of side effects. We have solved this key issue with TaxolCur™
bottom of page